RNA N6-METHYLADENOSINE WRITER METHYLTRANSFERASE LIKE 3 DRIVES IMMUNE SUPPRESSION IN COLORECTAL CANCER BY RECRUITING MDSC THROUGH CXCL1-CXCR2 AXIS

被引：0
|
作者：
Chen, Huarong
Pan, Yasi
Zhou, Qiming
Liu, Weixin
Zhai, Jianning
Wang, Feixue
Wong, Chi Chun
Yu, Jun
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su110
引用
收藏
页码：S621 / S621
页数：1
相关论文
共 48 条
  • [31] METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer
    Wan, Weijun
    Ao, Xiang
    Chen, Quan
    Yu, Yang
    Ao, Luoquan
    Xing, Wei
    Guo, Wei
    Wu, Xiaofeng
    Pu, Chengxiu
    Hu, Xueting
    Li, Zhan
    Yao, Mengwei
    Luo, Donglin
    Xu, Xiang
    MOLECULAR CANCER, 2022, 21 (01)
  • [32] METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer
    Weijun Wan
    Xiang Ao
    Quan Chen
    Yang Yu
    Luoquan Ao
    Wei Xing
    Wei Guo
    Xiaofeng Wu
    Chengxiu Pu
    Xueting Hu
    Zhan Li
    Mengwei Yao
    Donglin Luo
    Xiang Xu
    Molecular Cancer, 21
  • [33] RNA N6-methyladenosine modification participates in miR-660/E2F3 axis-mediated inhibition of cell proliferation in gastric cancer
    He, Xiaobo
    Shu, Ying
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (06)
  • [34] METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer
    Chen, Huarong
    Pan, Yasi
    Zhou, Qiming
    Liang, Cong
    Wong, Chi-Chun
    Zhou, Yunfei
    Huang, Dan
    Liu, Weixin
    Zhai, Jianning
    Gou, Hongyan
    Su, Hao
    Zhang, Xiaoting
    Xu, Hongzhi
    Wang, Yifei
    Kang, Wei
    Wu, William Ka Kei
    Yu, Jun
    GASTROENTEROLOGY, 2022, 163 (04) : 891 - 907
  • [35] N6-methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1/HK2 modification
    Qianqing Wang
    Xiangcui Guo
    Li Li
    Zhihui Gao
    Xiaoke Su
    Mei Ji
    Juan Liu
    Cell Death & Disease, 11
  • [36] N6-methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1/HK2 modification
    Wang, Qianqing
    Guo, Xiangcui
    Li, Li
    Gao, Zhihui
    Su, Xiaoke
    Ji, Mei
    Liu, Juan
    CELL DEATH & DISEASE, 2020, 11 (10)
  • [37] CircPTPRA blocks the recognition of RNA N6-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression (vol 20, 68, 2021)
    Xie, Fei
    Huang, Chao
    Liu, Feng
    Zhang, Hui
    Xiao, Xingyuan
    Sun, Jiayin
    Zhang, Xiaoping
    Jiang, Guosong
    MOLECULAR CANCER, 2022, 21 (01)
  • [38] The N6-methyladenosine reader IGF2BP3 promotes bladder cancer progression through enhancing HSP90AB1 expression
    Chen, Xiaoqing
    Diao, Wenli
    Guo, Xinyue
    Cao, Wenmin
    Yang, Yang
    Xie, Tianlei
    Chen, Wei
    Yang, Lin
    Zhang, Qing
    Ding, Meng
    Guo, Hongqian
    FEBS JOURNAL, 2025,
  • [39] Methyltransferase Like-3-Mediated N6-Methyladenosine Modification of Long Noncoding RNA Hepatocyte Nuclear Factor 1a Antisense RNA 1/Hepatocyte Nuclear Factor 4a Antisense RNA 1 Regulates Cytochrome P450 Enzyme Expression
    Yu, Yihang
    Wang, Jingya
    Xiong, Zaihuan
    Du, Anqi
    Wang, Xiaofei
    Wang, Yiting
    Han, Shengna
    Wang, Pei
    Zhang, Lirong
    DRUG METABOLISM AND DISPOSITION, 2024, 52 (10) : 1104 - 1114
  • [40] Endothelial METTL3 (Methyltransferase-Like 3) Inhibits Fibrinolysis by Promoting PAI-1 (Plasminogen Activator Inhibitor-1) Expression Through Enhancing Jun Proto-Oncogene N6-Methyladenosine Modification
    Bai, Qin
    Lu, Yao
    Chen, Yanhua
    Zhang, Han
    Zhang, Weiwei
    Wu, Huang
    Wen, Aiqing
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (12) : 2877 - 2889
12345